Skip to content

Health insurance co-payment (co-pay) programs and patient drug assistance programs (PAPs) are critical services for thousands of U.S. residents with HIV and/or viral hepatitis who face out-of-pocket expenses associated with their treatment. The Fair Pricing Coalition (FPC) has negotiated co-pay programs with virtually every major HIV and viral hepatitis drug manufacturer—which will continue to be essential as more people with HIV and/or hepatitis are rolled into private insurance plans with the implementation of the Affordable Care Act—and is working on expanding PAPs, particularly the eligibility criteria for those on state AIDS Drug Assistance Program (ADAP) waiting lists.

The FPC has published lists of co-pay programs and PAPs for people with HIV and hepatitis B and C. The lists include eligibility criteria and contact information for these programs. The lists will be updated as changes to programs occur. Learn more at:

Back To Top